tiprankstipranks
Trending News
More News >
Lobe Sciences (LOBEF)
OTHER OTC:LOBEF

Lobe Sciences (LOBEF) Price & Analysis

Compare
17 Followers

LOBEF Stock Chart & Stats

$0.04
>-$0.01(-17.06%)
At close: 4:00 PM EST
$0.04
>-$0.01(-17.06%)

Lobe Sciences News

LOBEF FAQ

What was Lobe Sciences’s price range in the past 12 months?
Lobe Sciences lowest stock price was <$0.01 and its highest was $0.06 in the past 12 months.
    What is Lobe Sciences’s market cap?
    Lobe Sciences’s market cap is $7.06M.
      When is Lobe Sciences’s upcoming earnings report date?
      Lobe Sciences’s upcoming earnings report date is Feb 02, 2026 which is in 38 days.
        How were Lobe Sciences’s earnings last quarter?
        Currently, no data Available
        Is Lobe Sciences overvalued?
        According to Wall Street analysts Lobe Sciences’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Lobe Sciences pay dividends?
          Lobe Sciences does not currently pay dividends.
          What is Lobe Sciences’s EPS estimate?
          Lobe Sciences’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Lobe Sciences have?
          Lobe Sciences has 193,198,330 shares outstanding.
            What happened to Lobe Sciences’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Lobe Sciences?
            Currently, no hedge funds are holding shares in LOBEF
            What is the TipRanks Smart Score and how is it calculated?
            Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

              Company Description

              Lobe Sciences

              Lobe Sciences Ltd., a life sciences company, focuses on the research and development of psychedelic medicines. It develops psilocybin-based therapeutics in combination with N-acetylcysteine for the treatment of mild traumatic brain injuries and post-traumatic stress disorder, as well as devices for the efficient application of medications. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. is headquartered in Vancouver, Canada.

              Lobe Sciences (LOBEF) Earnings & Revenues

              Similar Stocks
              Company
              Price & Change
              Follow
              Ayurcann Holdings Corp.
              Willow Biosciences Inc
              1933 Industries
              Blueberries Medical
              4Front Ventures

              Ownership Overview

              41.63%58.37%
              41.63% Insiders
              ― Other Institutional Investors
              58.37% Public Companies and
              Individual Investors

              Options Prices

              Currently, No data available
              ---
              Popular Stocks